PARP Inhibitor Market, By Drug (Lynparza, Niraparib, Rucaparib and Others), By Indication (Ovarian cancer, Breast cancer, Prostate cancer, Lung cancer and Others), By Distribution Channel (Hospital pharmacies, Online pharmacies and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034

PARP Inhibitor Market is projected to grow at a CAGR of 18.3% to reach US$ 67.0 billion by 2034

预计至2034年，PARP抑制剂市场将以18.3%的复合年增长率增长，市场规模将达到670亿美元。